Plain-English translation of NCT07423065 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a small, wearable glucose monitoring device (CGM) to see if it can help people with prediabetes and obesity make healthier changes to their diet and exercise habits, and lose weight. The study compares two versions of the device: one that shows you your blood sugar readings in real time, and one that doesn't show you the readings until later. Researchers want to understand whether seeing your glucose numbers as they happen helps you make better choices and improves your overall health.
Prediabetes and obesity are serious warning signs that type 2 diabetes may develop. The earlier people can make healthy changes, the better their chances of preventing diabetes and its complications. This study exists to find out whether this monitoring device can motivate lasting lifestyle changes and help people avoid developing diabetes.
You would wear a small glucose-monitoring sensor on your skin for about 5 months total, with clinic visits at the beginning and end of each phase. The study has two main periods of 12 weeks each, separated by a 30-day break. In one period, your device will show you your blood sugar numbers in real time so you can see how foods and activity affect your glucose; in the other period, the device will record your data but you won't see the readings. During clinic visits, you'll have measurements taken (weight, blood tests) and answer questions about your eating and exercise habits.
AI-generated summary from trial data · Oct 3, 2026 · Not medical advice
Slovenia